ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.With headquarters in Dublin, Ireland, ICON currently operates from 84 locations in 40 countries and has approximately 8,500 employees. Over 1,400 of these employees are based in 13 different countries throughout Asia Pacific. ICON Clinical Research specialises in the planning management, execution and analysis of Phase IIb – IV clinical trials, ranging from small studies to complex, multinational projects.